Manganese: A unique neuroimaging contrast agent

Future Neurology

Volumn 2, Issue 3, 2007, Pages 297-305

  Bock, Nicholas A ^a   Silva, Afonso C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Animal models of disease; Basal ganglia; CNS; Contrast agent; Functional imaging; Magnetic resonance imaging; Neuronal tract tracer

Indexed keywords

CALCIUM; CONTRAST MEDIUM; MANGAFODIPIR; MANGANESE; MANGANESE CHLORIDE; SUPERPARAMAGNETIC IRON OXIDE; TRACER;

BRAIN DAMAGE; BRAIN FUNCTION; CALCIUM TRANSPORT; CONTRAST ENHANCEMENT; DRUG MEGADOSE; DRUG SAFETY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IN VIVO STUDY; INTOXICATION; LOW DRUG DOSE; NERVE FUNCTION; NERVE TRACT; NEUROANATOMY; NEUROIMAGING; NEUROPATHOLOGY; NEUROTOXICITY; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL EXPOSURE; OPTIC NERVE INJURY; PARKINSONISM; PRIORITY JOURNAL; REVIEW; SIGNAL NOISE RATIO;

EID: 34249334993     PISSN: 14796708     EISSN: None     Source Type: Journal    
DOI: 10.2217/14796708.2.3.297     Document Type: Review

References (53)

1. Jasanoff A: Functional MRI using molecular imaging agents. Trends Neurosci. 28(3), 120-126 (2005).
2. Koretsky AP, Silva AC: Manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed. 17(8), 527-531 (2004).
3. Lauterbur PC: Image formation by induced local interactions - examples employing nuclear magnetic-resonance. Nature 242(5394), 190-191 (1973).
4. Aschner M, Erikson KM, Dorman DC: Manganese dosimetry: species differences and implications for neurotoxicity. Crit. Rev. Toxicol. 35(1), 1-32 (2005).
5. Wedler FC, Denman RB: Glutamine synthetase: the major MnII enzyme in mammalian brain. Curr. Top. Cell. Regul. 24, 153-169 (1984).
6. Dobson AW, Erikson KM, Aschner M: Manganese neurotoxicity. Ann. NY Acad. Sci. 1012, 115-128 (2004).
7. Antonini JM, Santamaria AB, Jenkins NT, Albini E, Lucchini R: Fate of manganese associated with the inhalation of welding fumes: potential neurological effects. Neurotoxicology 27(3), 304-310 (2006).
8. Yu IJ, Park JD, Park ES et al.: Manganese distribution in brains of Sprague-Dawley rats after 60 days of stainless steel welding-fume exposure. Neurotoxicology 24(6), 777-785 (2003).
9. Cersosimo MG, Koller WC: The diagnosis of manganese-induced parkinsonism. Neurotoxicology 27(3), 340-346 (2006).
10. Erikson KM, Thompson K, Aschner J, Aschner M: Manganese neurotoxicity: a focus on the neonate. Pharmacol. Ther. 113(2), 369-377 (2007).
11. Pal PK, Samii A, Calne DB: Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology 20(2-3), 227-238 (1999).
12. Jiang Y, Zheng W, Long L et al.: Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: search for biomarkers of manganese exposure. Neurotoxicology 28(1), 126-135 (2007).
13. 1-weighted hyperintensity in basal ganglia at brain magnetic resonance imaging: are different pathologies sharing a common mechanism? Neurotoxicology 23(6), 669-674 (2002).
14. Silva AC, Lee JH, Aoki I, Koretsky AP: Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed. 17(8), 532-543 (2004).
15. Aoki I, Wu YJ, Silva AC, Lynch RM, Koretsky AP: In vivo detection of neuroarchitecture in the rodent brain using manganese-enhanced MRI. Neuroimage 22(3), 1046-1059 (2004).
16. 2 for dynamic manganese-enhanced MRI. Magn. Reson. Med. 51(5), 978-987 (2004).
17. Gunter TE, Gavin CE, Aschner M, Gunter KK: Speciation of manganese in cells and mitochondria: a search for the proximal cause of manganese neurotoxicity. Neurotoxicology 27(5), 765-776 (2006).
18. Takeda A, Sawashita J, Okada S: Biological half-lives of zinc and manganese in rat brain. Brain Res. 695(1), 53-58 (1995).
19. Sloot WN, Gramsbergen JB: Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res. 657(1-2), 124-132 (1994).
20. Pautler RG, Mongeau R, Jacobs RE: In vivo trans-synaptic tract tracing from the murine striatum and amygdala utilizing manganese enhanced MRI (MEMRI). Magn. Reson. Med. 50(1), 33-39 (2003).
21. Pautler RG, Silva AC, Koretsky AP: In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn. Reson. Med. 40(5), 740-748 (1998).
22. 1 contrast. Magn. Reson. Med. 53(3), 640-648 (2005).
23. Tindemans I, Boumans T, Verhoye M, Van der Linden A: IR-SE and IR-MEMRI allow in vivo visualization of oscine neuroarchitecture including the main forebrain regions of the song control system. NMR Biomed. 19(1), 18-29 (2006).
24. Bock NA, Kovacevic N, Lipina TV, Roder JC, Ackerman SL, Henkelman RM: In vivo magnetic resonance imaging and semiautomated image analysis extend the brain phenotype for cdf/cdf mice. J. Neurosci. 26(17), 4455-4459 (2006).
25. Aoki I, Naruse S, Tanaka C: Manganese-enhanced magnetic resonance imaging (MEMRI) of brain activity and applications to early detection of brain ischemia. NMR Biomed. 17(8), 569-580 (2004).
26. Henning EC, Meng X, Fisher M, Sotak CH: Visualization of cortical spreading depression using manganese-enhanced magnetic resonance imaging. Magn. Reson. Med. 53(4), 851-857 (2005).
27. Wei Q, Clarke L, Scheidenhelm DK et al.: High-grade glioma formation results from postnatal PTEN loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model. Cancer Res. 66(15), 7429-7437 (2006).
28. Mori S, Zhang J: Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 51(5), 527-539 (2006).
29. Pautler RG, Koretsky AP: Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging. Neuroimage 16(2), 441-448 (2002).
30. Natt O, Watanabe T, Boretius S, Radulovic J, Frahm J, Michaelis T: High-resolution 3D MRI of mouse brain reveals small cerebral structures in vivo. J. Neurosci. Methods 120(2), 203-209 (2002).
31. Bilgen M, Peng W, Al-Hafez B, Dancause N, He YY, Cheney PD: Electrical stimulation for cortex improves corticospinal tract tracing in rat spinal cord using manganese-enhanced MRI. J. Neurosci. Methods 156(1-2), 17-22 (2006).
32. Murayama Y, Weber B, Saleem KS, Augath M, Logothetis NK: Tracing neural circuits in vivo with Mn-enhanced MRI. Magn. Reson. Imaging 24(4), 349-358 (2006)
33. Van der Linden A, Van Meir MV, Tindemans I, Verhoye M, Balthazart J: Applications of manganese-enhanced magnetic resonance imaging (MEMRI) to image brain plasticity in song birds. NMR Biomed. 17(8), 602-612 (2004).
34. Whone AL, Moore RY, Piccini PP, Brooks DJ: Plasticity of the nigropallidal pathway in Parkinson's disease. Ann. Neurol. 53(2), 206-213 (2003).
35. Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R: Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain 129(Pt 4), 1059-1069 (2006).
36. van der Zijden JP, Wu O, van der Toom TA, Roeling TP, Bleys RL, Dijkhuizen RM: Changes in neuronal connectivity after stroke in rats as studied by serial manganese-enhanced MRI. Neuroimage 34(4), 1650-1657 (2007).
37. Nairismagi J, Pitkanen A, Narkilahti S, Huttunen J, Kauppinen RA, Grohn OH: Manganese-enhanced magnetic resonance imaging of mossy fiber plasticity in vivo. Neuroimage 30(1), 130-135 (2006).
38. 2. NMR Biomed. 16(5), 252-256 (2003).
39. Thuen M, Singstad TE, Pedersen TB et al.: Manganese-enhanced MRI of the optic visual pathway and optic nerve injury in adult rats. J. Magn. Reson. Imaging 22(4), 492-500 (2005).
40. Bilgen M: Imaging corticospinal tract connectivity in injured rat spinal cord using manganese-enhanced MRI. BMC Med. Imaging 6, 15 (2006).
41. Bilgen M, Dancause N, Al-Hafez B, He YY, Malone TM: Manganese-enhanced MRI of rat spinal cord injury. Magn. Reson. Imaging 23(7), 829-832 (2005).
42. Stieltjes B, Klussmann S, Bock M et al.: Manganese-enhanced magnetic resonance imaging for in vivo assessment of damage and functional improvement following spinal cord injury in mice. Magn. Reson. Med. 55(5), 1124-1131 (2006).
43. 1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn. Reson. Med. 38(3), 378-388 (1997).
44. Aoki I, Tanaka C, Takegami T et al.: Dynamic activity-induced manganese-dependent contrast magnetic resonance imaging (DAIM MRI). Magn. Reson. Med. 48(6), 927-933 (2002).
45. Duong TQ, Silva AC, Lee SP, Kim SG: Functional MRI of calcium-dependent synaptic activity: cross correlation with CBF and BOLD measurements. Magn. Reson. Med. 43(3), 383-392 (2000).
46. Yu X, Wadghiri YZ, Sanes DH, Turnbull DH: In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat. Neurosci. 8(7), 961-968 (2005).
47. Kuo YT, Herlihy AH, So PW, Bell JD: Manganese-enhanced magnetic resonance imaging (MEMRI) without compromise of the blood-brain barrier detects hypothalamic neuronal activity in vivo. NMR Biomed. 19(8), 1028-1034 (2006).
48. Lim KO, Stark DD, Leese PT, Pfefferbaum A, Rocklage SM, Quay SC: Hepatobiliary MR imaging: first human experience with MnDPDP. Radiology 178(1), 79-82 (1991).
49. Skjold A, Vangberg TR, Kristoffersen A, Haraldseth O, Jynge P, Larsson HB: Relaxation enhancing properties of MnDPDP in human myocardium. J. Magn. Reson. Imaging 20(6), 948-952 (2004).
50. 1 mapping. Magn. Reson. Med. 55(3), 604-611 (2006).
51. Bellin MF: MR contrast agents, the old and the new. Eur. J. Radiol. 60(3), 314-323 (2006).
52. Jander S, Schroeter M, Saleh A: Imaging inflammation in acute brain ischemia. Stroke 38(2), 642-645 (2007).
53. Enochs WS, Harsh G, Hochberg F, Weissleder R: Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J. Magn. Reson. Imaging 9(2), 228-232 (1999).